Research Portal

All Wales Medicines Strategy Group Final Appraisal Report - Pegfilgrastim (Neulasta) for the reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with cytotoxic chemotherapy for malignancy.

Research output: Book/Report › Commissioned report

  • D. Hughes
  • D.A. Hughes
  • [No Value] All Wales Strategy Group.
Original languageEnglish
PublisherUnknown
Commissioning bodyNHS Wales
Edition2008
Publication statusPublished - 1 Jan 2008
View graph of relations